☰
Genomic Vision, a molecular diagnostics and technology company that develops tools and services focused on examining and controlling changes in the genome, has recently announced the unveiling of TeloSizer®, an advanced solution that will aid in enhancing the offerings of the firm in the telomere biology field and cellular health analysis.
TeloSizer® is based on Genomic Vision's patented molecular combing technology and FiberSmart®, its early access tool that identifies, captures pictures, and measures telomere length on single DNA molecules.
Telomeres are DNA-binding structures located at the ends of chromosomes that prevent DNA from being lost during DNA replication.
Shrinking of telomere is a natural process that contributes to cell senescence and aging in humans. Unprogrammed telomere lengthening has been linked to the beginning of numerous illnesses, including cancer.
In recent years, the Health Adjusted Life Expectancy (HALE) has aided in creating a $2 billion worldwide cellular health screening market.
A part of the cellular health industry is focused on understanding how telomere length may be detected as a biomarker in cell aging and illnesses such as cancer, neurological diseases, and other telomeropathies.
As per Dominique Remy-Renou, CEO of Genomic Vision, ‘TeloSizer® would assist in accelerating the development of innovative solutions that meet unfulfilled requirements in the healthcare, pharmaceutical, and biotechnology industries’.
‘TeloSizer® makes it possible to discover novel telomere length biomarkers or, perhaps more significantly, to validate current telomere length biomarkers’.
Sources cite that the addition of TeloSizer® to Genomic Vision’s service offering and the utility of molecular combing is a significant step forward.
TeloSizer® will serve in a new application area that combines with the current market products such as structural variation analysis, DNA replication analysis, and copy number variation.
It further demonstrates how Genomic Vision is offering exclusive products and services for the classification of genome preservation, a crucial set of conditions that will be needed for forthcoming work in cellular health and personalized medicine.
Meta, the leading American technology company and the owner of social media platforms Facebook and Instagram, has reportedly announced its plans to lay off around 10,000 employees. Apparently, this is going to be the second round of significant la...
Heathrow Airport, the U.K.’s leading international airport, has reportedly been advised to reduce passenger costs for airlines next year, as they would have an impact on ticket pricing. The Civil Aviation Authority (CAA) determined that lowe...
Amazon, the U.S.-based e-commerce giant, has reportedly inked a deal with struggling mortgage lender, Better.com to provide better perks to employees. For the unversed, Better.com is introducing Equity Unlocker, a product that enables staff member...
© 2024 IntelligenceJournal.com. All Rights Reserved.
